NH HB524

Repeals RSA 126-Q, which established the New Hampshire Vaccine Association (NHVA), eliminating the organization that collects payments from approximately 80 commercial payers to reimburse the state for childhood vaccines

Would result in a $24 million annual decrease in NHVA revenue and corresponding decrease in state vaccine expenditures, shifting responsibility for purchasing and billing vaccines to individual provider sites for privately-insured patients under age 19

Creates approximately $150,000 in new general fund costs in FY26 and $100,000 annually thereafter for the Department of Health and Human Services to purchase vaccines during public health emergencies and disease outbreaks

Health insurers would lose approximately 30% savings on vaccine list prices currently achieved through the universal purchasing program, potentially increasing healthcare costs and insurance premiums

Takes effect 60 days after passage